- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Pemphigus vulgaris is an autoimmune disease. It usually starts with vesicles in the mouth and then spreads to the skin or genital mucous membranes. The blisters are typically painful but do not itch. Blisters in the mouth or throat can make swallowing and eating difficult.
Showing all 12 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD20 |
Biosimilar , Monoclonal Antibody |
Ruxience® |
10 mg/mL |
– |
2 mg |
tba |
tba |
196,00 € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Truxima® |
10 mg/mL |
– |
2 mg |
tba |
tba |
234,00 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2018.05 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2018.09 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2018.12 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.02 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.02 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.08 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.12 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2021.07 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
4 mg |
-80°C |
2026.04 |
196,00 € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Rixathon® |
10 mg/mL |
– |
2 mg |
-80 °C |
2026.03 |
311,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany